Written by Private MD Labs Medical Writing Team • Last Updated: September 8, 2025
Hemophilia is a genetic bleeding disorder that impairs the body's ability to form blood clots properly. This condition is caused by deficiencies in specific clotting factors, leading to prolonged bleeding episodes. Blood tests that measure clotting function are essential for diagnosing hemophilia and determining its severity.
This comprehensive coagulation panel is fundamental for hemophilia diagnosis. The PTT portion is particularly important as it becomes prolonged when there are deficiencies in clotting factors commonly affected in hemophilia. This test helps identify the presence of a bleeding disorder and guides further specialized testing to determine the specific type and severity of hemophilia.
Hemophilia diagnosis relies on specialized blood tests that evaluate how well the blood clots. These coagulation tests can detect abnormalities in the clotting cascade and identify which clotting factors are deficient. Early and accurate diagnosis is crucial for proper management and treatment planning.
While the PT/INR test primarily evaluates a different clotting pathway, it can also show prolonged results in hemophilia cases. This test helps healthcare providers get a complete picture of the clotting system function and can assist in differentiating hemophilia from other bleeding disorders, ensuring comprehensive evaluation of coagulation status.
Prolonged clotting times in these tests may indicate hemophilia, but additional specialized factor assays are typically needed to confirm the diagnosis and determine the specific type (Hemophilia A or B) and severity. Your healthcare provider will interpret these results in conjunction with your medical history and symptoms.
The information here is for educational purposes only and is not a substitute for professional medical advice. Always consult with a healthcare provider for diagnosis and treatment.